Stock Analysis of Artelo Biosciences Inc (ARTL) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code ARTL
Close 1.42
Change 0.060 / 4.41 %
Volume 25562.00
Vol Change 23593.00 / 1198.22 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthMild Bullish
Growth Index Mild Growth
Value Index Low Value Stock
Profitability Index Poor Profitability Stock
Stability Index No Significant Stability


Fundamental View of Artelo Biosciences Inc
PE (TTM)

-0.447

Very Poor
Price / Book

0.300

Excellent
Price / Sales

0

Very Poor
Piotroski F Score

2.0

Poor
Market Cap

4583.33 K

Enterprise Value

-2264.67 K

ROA (TTM)

-63.02

Very Poor
ROE (TTM)

-67.13

Very Poor
Net Margin (TTM)

0

Poor
Revenue

%

0
Net Profit

2.07 %

-9874.00 K
Debt to Equity

0.0021

Excellent
Altman Z Score

-0.492

Very Poor
Quick Ratio

0

Poor
Cash Ratio

17.57

Excellent


Highs/Lows of Artelo Biosciences Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week1.34 5.97 % 1.54 % 1.451.2717-May-2413-May-24
Two Week1.35 5.19 % 3.42 % 1.451.2717-May-2413-May-24
One Month1.315 7.98 % 5.60 % 1.451.2517-May-2418-Apr-24
Three Month1.67 14.97 % 5.95 % 1.7191.2522-Feb-2418-Apr-24
Six Months1.18 20.34 % 17.48 % 1.751.1714-Feb-2422-Nov-23
One year1.71 16.96 % 27.52 % 2.981.1607-Sep-2317-Nov-23
Two year4.959 71.37 % 29.70 % 3.691.1605-Oct-2217-Nov-23
Five year120.0 98.82 % 85.46 % 5.35531.1618-Aug-2231-Oct-23


Technical View of Artelo Biosciences Inc
RSI

54.96

Neutral
MACD

-0.0179

Bullish
ADX

25.33

Mild Bullish
Super Trend

1.55

Mild Bearish
Williams %R

-15.81

Mild Bearish
CCI

249.64

Mild Bearish


EMA 5

1.37

Strong Bullish
EMA 15

1.35

Bullish
EMA 50

1.40

Strong Bullish
EMA 100

1.44

Mild Bearish
SMA 100

1.45

Mild Bearish
SMA 200

1.49

Mild Bearish
SMA 5 / 20

1.35 / 1.34

Whipsaw
SMA 15 / 50

1.34 / 1.43

Mild Bearish
SMA 50 / 200

1.43 / 1.49

Mild Bearish




Charts of Artelo Biosciences Inc


Returns of Artelo Biosciences Inc with Peers
Period / StockARTLTHMOVRAYNEXI
1 Week5.97%-12.40%-71.72%-7.33%
1 Mth7.98%-6.84%-93.41%5.90%
3 Mth-14.97%-45.38%-97.83%-57.12%
6mth20.34%-42.74%-99.46%34.52%
1 Year-16.96%-67.57%-99.16%-55.52%
2 Year-71.37%-96.57%-99.61%-93.46%
5 Years-98.82%-99.52%-99.79%-
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Artelo Biosciences Inc with Peers
Ratio / StockARTLTHMOVRAYNEXI
PE-0.447-0.095-0.0403-0.095
P/B0.3002.530.04400.0006
ROA-63.02-131.38-41.89-0.458
ROE-67.13-911.89-109.19-0.596
Debt To Equity0.0021-4.590.9870.0196
Revenue0
% 		9715.00 K
7.33 % 		102206 K
45.76 % 		0
%
Net Income-9874.00 K
2.07 % 		-14394.00 K
27.72 % 		-107330.00 K
2.47 % 		-43878.79 K
99.93 %


Technicals of Artelo Biosciences Inc with Peers
Technical / StockARTLTHMOVRAYNEXI-
ADX25.3313.7758.9213.55
CMF-0.079-0.456-0.326-0.124
MFI40.1138.255.7163.01
RSI54.9639.0719.9840.87
MACD Abv SignalTrueFalseFalseTrue
Price Above 50 MAFalseFalseFalseFalse-
Price Above 200 MAFalseFalseFalseFalse-


About : Artelo Biosciences Inc

Address : 505 Lomas Santa Fe, Solana Beach, CA, United States, 92075
Tel : 858 925 7049
URL : https://www.artelobio.com
Code : ARTL, ISIN : US04301G2012, Exchange : NASDAQ, Country : USA
Fiscal Year End : August
IPO date : 14_Nov_2017
Employee Count : 6

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. It's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment anxiety, post-traumatic stress disorder, epilepsy, inflammatory bowel disease, and other potential indications; and ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.


Note : All Data Generated at the End of Trading Hours (EOD Data)